{
     "PMID": "24384407",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20141014",
     "LR": "20140210",
     "IS": "1879-0712 (Electronic) 0014-2999 (Linking)",
     "VI": "724",
     "DP": "2014 Feb 5",
     "TI": "Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats.",
     "PG": "132-9",
     "LID": "10.1016/j.ejphar.2013.12.028 [doi] S0014-2999(13)00956-4 [pii]",
     "AB": "Bipolar disorder (BD) is a chronic and debilitating illness characterized by recurrent manic and depressive episodes. Our research investigates the protective effects of curcumin, the main curcuminoid of the Indian spice turmeric, in a model of mania induced by ketamine administration in rats. Our results indicated that ketamine treatment (25 mg/kg, for 8 days) induced hyperlocomotion in the open-field test and oxidative damage in prefrontal cortex (PFC) and hippocampus (HP), evaluated by increased lipid peroxidation and decreased total thiol content. Moreover, ketamine treatment reduced the activity of the antioxidant enzymes superoxide dismutase and catalase in the HP. Pretreatment of rats with curcumin (20 and 50 mg/kg, for 14 days) or with lithium chloride (45 mg/kg, positive control) prevented behavioral and pro-oxidant effects induced by ketamine. These findings suggest that curcumin might be a good compound for preventive intervention in BD, reducing the episode relapse and the oxidative damage associated with the manic phase of this disorder.",
     "CI": [
          "Copyright (c) 2013 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Gazal, Marta",
          "Valente, Matheus R",
          "Acosta, Bruna A",
          "Kaufmann, Fernanda N",
          "Braganhol, Elizandra",
          "Lencina, Claiton L",
          "Stefanello, Francieli M",
          "Ghisleni, Gabriele",
          "Kaster, Manuella P"
     ],
     "AU": [
          "Gazal M",
          "Valente MR",
          "Acosta BA",
          "Kaufmann FN",
          "Braganhol E",
          "Lencina CL",
          "Stefanello FM",
          "Ghisleni G",
          "Kaster MP"
     ],
     "AD": "Programa de Pos-Graduacao em Saude e Comportamento, Universidade Catolica de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Programa de Pos-Graduacao em Saude e Comportamento, Universidade Catolica de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Programa de Pos-Graduacao em Saude e Comportamento, Universidade Catolica de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Programa de Pos-Graduacao em Saude e Comportamento, Universidade Catolica de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Programa de Pos-Graduacao em Saude e Comportamento, Universidade Catolica de Pelotas, Pelotas, Rio Grande do Sul, Brazil. Electronic address: ghisleni.g@gmail.com. Programa de Pos-Graduacao em Saude e Comportamento, Universidade Catolica de Pelotas, Pelotas, Rio Grande do Sul, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20131230",
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Antimanic Agents)",
          "0 (Antioxidants)",
          "0 (Neuroprotective Agents)",
          "0 (Thiobarbituric Acid Reactive Substances)",
          "690G0D6V8H (Ketamine)",
          "EC 1.11.1.6 (Catalase)",
          "EC 1.15.1.1 (Superoxide Dismutase)",
          "IT942ZTH98 (Curcumin)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antimanic Agents/pharmacology/*therapeutic use",
          "Antioxidants/pharmacology/*therapeutic use",
          "Behavior, Animal/drug effects",
          "Bipolar Disorder/chemically induced/*drug therapy/metabolism",
          "Catalase/metabolism",
          "Curcumin/pharmacology/*therapeutic use",
          "Female",
          "Hippocampus/drug effects/metabolism",
          "Ketamine",
          "Motor Activity/drug effects",
          "Neuroprotective Agents/pharmacology/*therapeutic use",
          "Oxidative Stress/drug effects",
          "Prefrontal Cortex/drug effects/metabolism",
          "Rats",
          "Rats, Wistar",
          "Superoxide Dismutase/metabolism",
          "Thiobarbituric Acid Reactive Substances/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Antioxidant",
          "Curcumin",
          "Ketamine",
          "Mania",
          "Neuroprotective"
     ],
     "EDAT": "2014/01/05 06:00",
     "MHDA": "2014/10/15 06:00",
     "CRDT": [
          "2014/01/04 06:00"
     ],
     "PHST": [
          "2013/09/28 00:00 [received]",
          "2013/12/12 00:00 [revised]",
          "2013/12/18 00:00 [accepted]",
          "2014/01/04 06:00 [entrez]",
          "2014/01/05 06:00 [pubmed]",
          "2014/10/15 06:00 [medline]"
     ],
     "AID": [
          "S0014-2999(13)00956-4 [pii]",
          "10.1016/j.ejphar.2013.12.028 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 2014 Feb 5;724:132-9. doi: 10.1016/j.ejphar.2013.12.028. Epub 2013 Dec 30.",
     "term": "hippocampus"
}